3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is increasingly attracting researcher scrutiny due to initial information suggesting distinct physiological characteristics. Preliminary analyses indicate that 3-HPC may exhibit separate impacts on the central structure, possibly contributing to some of the unanticipated sy